| Style | Citing Format |
|---|---|
| MLA | Ahmadiany M, et al.. "The Increased Rnase Activity of Ire1α in Pbmcs From Patients With Rheumatoid Arthritis." Advanced Pharmaceutical Bulletin, vol. 9, no. 3, 2019, pp. 505-509. |
| APA | Ahmadiany M, Alavisamani M, Hashemi Z, Moosavi MA, Rahmati M (2019). The Increased Rnase Activity of Ire1α in Pbmcs From Patients With Rheumatoid Arthritis. Advanced Pharmaceutical Bulletin, 9(3), 505-509. |
| Chicago | Ahmadiany M, Alavisamani M, Hashemi Z, Moosavi MA, Rahmati M. "The Increased Rnase Activity of Ire1α in Pbmcs From Patients With Rheumatoid Arthritis." Advanced Pharmaceutical Bulletin 9, no. 3 (2019): 505-509. |
| Harvard | Ahmadiany M et al. (2019) 'The Increased Rnase Activity of Ire1α in Pbmcs From Patients With Rheumatoid Arthritis', Advanced Pharmaceutical Bulletin, 9(3), pp. 505-509. |
| Vancouver | Ahmadiany M, Alavisamani M, Hashemi Z, Moosavi MA, Rahmati M. The Increased Rnase Activity of Ire1α in Pbmcs From Patients With Rheumatoid Arthritis. Advanced Pharmaceutical Bulletin. 2019;9(3):505-509. |
| BibTex | @article{ author = {Ahmadiany M and Alavisamani M and Hashemi Z and Moosavi MA and Rahmati M}, title = {The Increased Rnase Activity of Ire1α in Pbmcs From Patients With Rheumatoid Arthritis}, journal = {Advanced Pharmaceutical Bulletin}, volume = {9}, number = {3}, pages = {505-509}, year = {2019} } |
| RIS | TY - JOUR AU - Ahmadiany M AU - Alavisamani M AU - Hashemi Z AU - Moosavi MA AU - Rahmati M TI - The Increased Rnase Activity of Ire1α in Pbmcs From Patients With Rheumatoid Arthritis JO - Advanced Pharmaceutical Bulletin VL - 9 IS - 3 SP - 505 EP - 509 PY - 2019 ER - |